Home>Media>Newsroom – 2015 Media Newsroom - 2015 Glenmark Pharmaceuticals receives ANDA approval for Linezolid Tablets 22 DEC 2015 | READ MORE Glenmark Pharmaceuticals announces the settlement of Paragraph IV litigation with Forest Laboratories 21 DEC 2015 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Clotrimazole and Betamethasone Dipropionate Cream 9 NOV 2015 | READ MORE Glenmark Pharmaceuticals receives tentative ANDA approval for Lacosamide Tablets 30 OCT 2015 | READ MORE Glenmark’s Consolidated Revenue increases in Q2 FY 15-16 29 OCT 2015 | READ MORE Glenmark announces Strategic Development & Licensing Agreement with Celon, Poland for generic Seretide Accuhaler® in Europe. 23 OCT 2015 | READ MORE Glenmark’s Bi-Specific Antibody - GBR 1302 to enter Phase I trials. 15 SEP 2015 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Voriconazole Tablets 5 SEP 2015 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Voriconazole Tablets 4 SEP 2015 | READ MORE Glenmark’s novel monoclonal antibody GBR 830 to enter Phase 2 clinical studies in Atopic Dermatitis and Celiac Disease in US and Europe 3 SEP 2015 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Drospirenone and Ethinyl Estradiol Tablet 9 AUG 2015 | READ MORE Glenmark’s Consolidated Revenue increases in Q1 FY 15-16 30 JUL 2015 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Levonorgestrel and Ethinyl Estradiol Tablets 15 JUN 2015 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Calcipotriene Cream 11 JUN 2015 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Desmopressin Acetate Tablets 29 MAY 2015 | READ MORE Glenmark Pharmaceuticals receives tentative ANDA approval for Calcipotriene Cream 4 MAY 2015 | READ MORE Glenmark Generics receives ANDA approval for Levonorgestrel and Ethinyl Estradiol Tablets 10 APR 2015 | READ MORE Glenmark receives final ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Tablets 7 APR 2015 | READ MORE Glenmark receives approval for generic Seretide® in Russia. 12 MAR 2015 | READ MORE Glenmark announces approval and launch of Trandolapril & Verapamil Hydrochloride (HCl) Extended Release Tablets in the US. 26 FEB 2015 | READ MORE Glenmark announces approval and launch of Ashlyna™ Extended. 25 FEB 2015 | READ MORE Glenmark’s consolidated revenue increases for Q3 FY 14 – 15 12 FEB 2015 | READ MORE Year – 2024 Year – 2023 Year – 2022 Year – 2021 Year – 2020 Year – 2019 Year – 2018 Year – 2017 Year – 2016 Year – 2015
